A rare case of Philadelphia chromosome-positive chronic myelogenous leukemia with inversion in chromosome 9 and t(10;17)

Rooney DE: Human Cytogenetics: Malignancy and Acquired Abnormalities. 3rd edition. Oxford University Press; New York: pp. 372001

Sessions J: Chronic myeloid leukemia in 2007. Am J Health Syst Pharm. 64:S4–S9. 2007. View Article : Google Scholar : PubMed/NCBI

Lugo T, Pendergast A, Müller A and Witte O: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science. 247:1079–1082. 1990. View Article : Google Scholar : PubMed/NCBI

Melo JV, Gordon DE, Cross NC and Goldman JM: The ABL-BCR fusion gene is expressed in chronic myeloid leukaemia. Blood. 81:158–165. 1993.PubMed/NCBI

Quintas-Cardama A, Kantarjian H, Talpaz M, O’Brien S, Garcia-Manero G, Verstovsek S, Rios M, Hayes K, Glassman A, Bekele B, Zhou X and Cortes J: Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood. 105:2281–2286. 2005. View Article : Google Scholar : PubMed/NCBI

Melo J, Hochhaus A, Yun X-H and Goldman J: Lack of correlation of ABL/BCR expression and response to interferon-α in chronic myeloid leukaemia. Br J Haematol. 92:684–686. 1996.PubMed/NCBI

Sandberg AA: The Chromosomes in Human Cancer and Leukemia. 2nd edition. Elsevier Science; New York: pp. 151–172. 1990

Rege-Cambrim G, Caidano G, Serra A, Scaravaglio P, Guglielmelli T, Guerrasio A, Giovinazzo B and Saglio G: Analysis of the p53 in myeloid malignancies associated with chromosomal abnormalities involving the short arm of chromosome 17. Leukemia. 8:23–26. 1994.PubMed/NCBI

Calabretta B and Perrotti D: The biology of CML blast crisis. Blood. 103:4010–4022. 2004. View Article : Google Scholar : PubMed/NCBI

Claussen U, Michel S, Mühlig P, Westermann M, Grummt UW, Kromeyer-Hauschild K and Liehr T: Demystifying chromosome preparation and the implications for the concept of chromosome condensation during mitosis. Cytogenet Genome Res. 98:136–146. 2002. View Article : Google Scholar : PubMed/NCBI

Shaffer L, Slovak M and Cambell L: ISCN 2009: An International System for Human Cytogenetic Nomenclature. S. Karger; Basel: 2009

Weise A, Mrasek K, Fickelscher I, Claussen U, Cheung SW, Cai WW, Liehr T and Kosyakova N: Molecular definition of high-resolution multicolor banding probes: first within the human DNA sequence anchored FISH banding probe set. J Histochem Cytochem. 56:487–493. 2008. View Article : Google Scholar : PubMed/NCBI

Liehr T, Heller A, Starke H, Rubtsov N, Trifonov V, Mrasek K, Weise A, Kuechler A and Claussen U: Microdissection based high resolution multicolor banding for all 24 human chromosomes. Int J Mol Med. 9:335–339. 2002.PubMed/NCBI

Mitelman F, Johansson B and Mertens F: Mitelman Database of Chromosome Aberrations in Cancer. 2009, http://cgap.nci.nih.gov/chromosomes/Mitelman.

Reid AG, Huntly BJ, Grace C, Green AR and Nacheva EP: Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. Br J Haematol. 121:419–427. 2003. View Article : Google Scholar : PubMed/NCBI

Johansson B, Fioretos T and Mitelman F: Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 107:76–94. 2002. View Article : Google Scholar : PubMed/NCBI

Imamura J, Miyoshi I and Koeffler HP: p53 in hematologic malignancies. Blood. 84:24121994.PubMed/NCBI